Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells

Islets

Volumn 6, Issue JAN, 2014, Pages

  Tamarina, Natalia A ^a   Roe, Michael W ^b   Philipson, L H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Calcium; Cre recombinase; Glucose tolerance; Ins1 gene promoter; Insulin secretion; Pancreatic islet; catenin

Indexed keywords

BETA CATENIN; BETA GALACTOSIDASE; CALCIUM; CRE RECOMBINASE; CREERT RECOMBINASE; CTNNB1 PROTEIN; ESTROGEN RECEPTOR; FAT; GLUCAGON; GLUCOSE; INSULIN; INSULIN 1; PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG; INS1 PROTEIN, MOUSE; INTEGRASE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; CYTOARCHITECTURE; EYE; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; GENETIC ANALYSIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HEART; HEMIZYGOTE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; INSULIN RELEASE; KIDNEY; LARGE INTESTINE; LIVER; LUNG; MALE; MOUSE; NONHUMAN; OVARY; PANCREAS; PANCREAS ISLET BETA CELL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SMALL INTESTINE; SPLEEN; STAINING; TISSUE SPECIFICITY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; GENE TARGETING; GENE TRANSFER; GENETICS; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; BETA CATENIN; FEMALE; GENE DELETION; GENE TARGETING; GENE TRANSFER TECHNIQUES; INSULIN; INSULIN-SECRETING CELLS; INTEGRASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN;

EID: 84901953809     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.27685     Document Type: Article

References (23)

1. Mallo M. Controlled gene activation and inactivation in the mouse. Front Biosci 2006; 11:313-27; PMID:16146733; http://dx.doi.org/10.2741/1799
2. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999; 274:305-15; PMID:9867845; http://dx.doi.org/10.1074/ jbc.274.1.305
3. Zhang H, Fujitani Y, Wright CV, Gannon M. Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase. Genesis 2005; 42:210-7; PMID:15986486; http://dx.doi.org/10.1002/gene.20137
4. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002; 129:2447-57; PMID:11973276
5. Wiebe PO, Kormish JD, Roper VT, Fujitani Y, Alston NI, Zaret KS, Wright CV, Stein RW, Gannon M. Ptf1a binds to and activates area III, a highly conserved region of the Pdx1 promoter that mediates early pancreas-wide Pdx1 expression. Mol Cell Biol 2007; 27:4093-104; PMID:17403901; http://dx.doi.org/ 10.1128/MCB.01978-06
6. Mori H, Inoki K, Münzberg H, Opland D, Faouzi M, Villanueva EC, Ikenoue T, Kwiatkowski D, MacDougald OA, Myers MG Jr., et al. Critical role for hypothalamic mTOR activity in energy balance. Cell Metab 2009; 9:362-74; PMID:19356717; http://dx.doi.org/10.1016/j.cmet.2009.03.005
7. Hara M, Wang X, Kawamura T, Bindokas VP, Dizon RF, Alcoser SY, Magnuson MA, Bell GI. Transgenic mice with green fluorescent protein-labeled pancreatic beta-cells. Am J Physiol Endocrinol Metab 2003; 284:E177-83; PMID:12388130
8. Park SY, Wang X, Chen Z, Powers AC, Magnuson MA, Head WS, Piston DW, Bell GI. Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene. Genesis 2005; 43:80-6; PMID:16108006; http://dx.doi.org/10.1002/gene.20157
9. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 1996; 93:10887-90; PMID:8855277; http://dx.doi.org/10.1073/pnas.93.20.10887
10. Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/ inactivation in the mouse. Dev Biol 2002; 244:305-18; PMID:11944939; http://dx.doi.org/10.1006/ dbio.2002.0597
11. Wicksteed B, Brissova M, Yan W, Opland DM, Plank JL, Reinert RB, Dickson LM, Tamarina NA, Philipson LH, Shostak A, et al. Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 2010; 59:3090-8; PMID:20802254; http://dx.doi.org/10.2337/ db10-0624
12. Dessimoz J, Bonnard C, Huelsken J, Grapin-Botton A. Pancreas-specific deletion of beta-catenin reveals Wnt-dependent and Wnt-independent functions during development. Curr Biol 2005; 15:1677-83; PMID:16169491; http://dx.doi.org/10.1016/j. cub.2005.08.037
13. Dabernat S, Secrest P, Peuchant E, Moreau-Gaudry F, Dubus P, Sarvetnick N. Lack of beta-catenin in early life induces abnormal glucose homeostasis in mice. Diabetologia 2009; 52:1608-17; PMID:19513688; http://dx.doi.org/10.1007/ s00125-009-1411-y
14. Murtaugh LC, Law AC, Dor Y, Melton DA. Beta-catenin is essential for pancreatic acinar but not islet development. Development 2005; 132:4663-74; PMID:16192304; http://dx.doi.org/10.1242/ dev.02063
15. Rulifson IC, Karnik SK, Heiser PW, ten Berge D, Chen H, Gu X, Taketo MM, Nusse R, Hebrok M, Kim SK. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci U S A 2007; 104:6247-52; PMID:17404238; http://dx.doi.org/10.1073/pnas.0701509104
16. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, Sommer L, Boussadia O, Kemler R. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 2001; 128:1253-64; PMID:11262227
17. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 1998; 8:1323-6; PMID:9843687; http://dx.doi.org/10.1016/ S0960-9822(07)00562-3
18. Ahrens MJ, Romereim S, Dudley AT. A re-evaluation of two key reagents for in vivo studies of Wnt signaling. Dev Dyn 2011; 240:2060-8; PMID:21793100; http://dx.doi.org/10.1002/dvdy.22704
19. Peng S, Zhu Y, Lü B, Xu F, Li X, Lai M. TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121,174 subjects. Mutagenesis 2013; 28:25-37; PMID:23188737; http://dx.doi.org/10.1093/ mutage/ges048
20. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21:70-1; PMID:9916792; http://dx.doi.org/10.1038/5007
21. Marshall BA, Tordjman K, Host HH, Ensor NJ, Kwon G, Marshall CA, Coleman T, McDaniel ML, Semenkovich CF. Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion. J Biol Chem 1999; 274:27426-32; PMID:10488074; http://dx.doi.org/10.1074/ jbc.274.39.27426
22. Roe MW, Worley JF 3rd, Qian F, Tamarina N, Mittal AA, Dralyuk F, Blair NT, Mertz RJ, Philipson LH, Dukes ID. Characterization of a Ca2+ release-activated nonselective cation current regulating membrane potential and [Ca2+]i oscillations in transgenically derived beta-cells. J Biol Chem 1998; 273:10402-10; PMID:9553098; http://dx.doi.org/10.1074/jbc.273.17.10402
23. Tamarina NA, Kuznetsov A, Rhodes CJ, Bindokas VP, Philipson LH. Inositol (1,4,5)-trisphosphate dynamics and intracellular calcium oscillations in pancreatic beta-cells. Diabetes 2005; 54:3073-81; PMID:16249428; http://dx.doi.org/10.2337/diabetes.54.11.3073